简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-04-25 10:04 Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers
2024-04-24 14:16 Rubedo Life Sciences and Beiersdorf Announce Multi-Year Partnership to Pioneer New Skin Care Products that Address Cellular Aging
2024-04-24 13:55 Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth
2024-04-24 11:32 ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting
2024-04-23 16:01 Hemohim, a Functional Food to Boost Immune System, Sparks Global Sensation
2024-04-23 10:52 Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capital
2024-04-23 10:33 Ochre Bio announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease
2024-04-23 10:06 AI Medical Service Inc. Signs Joint Research Agreement with Mahidol University in Thailand
2024-04-22 21:51 Toyoda Gosei Develops UV-C LED with World-Class Light Output
2024-04-18 11:00 Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
2024-04-18 10:07 The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report
2024-04-17 22:24 A new chapter for Medisca: Sanjay D. Goorachurn appointed as Chief Executive Officer
2024-04-16 17:56 MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002
2024-04-16 10:56 KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer
2024-04-12 10:34 Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.
2024-04-12 09:40 Global Drive to ‘Quit Like Sweden’ Will Save Millions of Smokers’ Lives
2024-04-09 19:22 Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring
2024-04-09 13:52 Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints
2024-04-09 10:08 Takeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional Food
2024-04-08 19:20 New Survey Results from Cloudbreak Pharma Highlight Disease Burden, Need for Non-surgical Treatment Options for Underdiagnosed and Undertreated Ocular Disease

Business Wire Weibo

Press Releases

Latest Releases